ctxr stock discussion
-0.01 (-0.61%) Log in to see them here or sign up to get started. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey. Citius Pharmaceuticals (NASDAQ:CTXR), Inc. (Nasdaq: CTXR) , a late-stage biopharmaceutical company developing and commercializing first-in-class critical care products, today Investing.com U.S. stocks were higher after the close on Thursday, as gains in the Oil & Gas, Utilities and Healthcare sectors led shares higher. Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. Visit a quote page and your recently viewed tickers will be displayed here. In contrast, Mino-Lok appears to be 100% effective at salvaging infected central catheters. Stock Message Boards. 966. To learn more, click here. CTXR is not currently paying a regular dividend. The Motley Fool has no position in any of the stocks mentioned. Change value during other periods is calculated as the difference between the last trade and the most recent settle. 3 Stocks That Are Poised to Plunge. Just click the link Still, any dispute over the efficacy of a company's most advanced project is bad news, especially when that project is intended for its largest target market. You demand trustworthy DD for free from user of free stocks platform. The average price target represents a 227.87% change from the last price of $1.53. . That could make this company a pioneer in that niche of care. Source: FactSet. . CTXR Stock 12 Months Forecast. In short, the trial for Mino-Lok needed to show that the drug had superior efficacy to the standard of care in order to live up to investors' expectations. Daily Stock Discussion - Tuesday June 29th, 2021. Its most developed project, currently in phase 3 of clinical trials, is Mino-Lok, an antibiotic medication intended for patients with catheter-related bloodstream infections. First off, though, it's important to examine this company's stock. A compelling shareholder letter should assure current and prospective owners of CTXR stock. In fact, it has already received a Qualified Infectious Disease Product (QIDP) designation from the U.S. Food and Drug Administration (FDA). Data . Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. quotes delayed at least 15 minutes, all others at least 20 minutes. Get the latest Citius Pharmaceuticals, Inc CTXR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. View Citius Pharmaceuticals, Inc CTXR investment & stock information. Intraday data delayed at least 15 minutes or per exchange requirements. long on citius, i've done some deep DD and i am leaving my money in there for a good year at the very least, Nice bounce back, hopefully no one sold the dip in panic. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service. Let's do some quick math to see if that might be enough to make millions. All Rights Reserved. This is a technical indicator that can be used to analyze the stock's current value and predict future price movement. The average price-to-sales ratio (P/S) for a biotech stock is 8.09. Picking up a position in a healthcare stock ahead of a major catalyst can be a risky strategy but is also one that serves up the potential for a high degree of reward on the Citius Pharmaceuticals IncMino-LokMino-WrapHalo-LidoNoveCiteI/ONTAKI/ONTAKIL-2TMino-LokHalo-LidoMino-WrapNoveCiteARDS, Citius Pharmaceuticals Inc stock price live 1.650, this page displays NASDAQ CTXR stock exchange data. Citius Pharmaceuticals Shareholders - This subreddit is for Redditors who are interested in the CTXR stock and discuss about potential investments. Source: FactSet, Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. Ls vr integritetspolicy och cookiepolicy fr att f mer information om hur vi anvnder dina personuppgifter. Find the latest Citius Pharmaceuticals, Inc. (CTXR) stock quote, history, news and other vital information to help you with your stock trading and investing. Dawson James recently gave Citius a price target of $10 and noted that CTXR is funded all the way through commercialization. Let's try to keep the stock chatter centralized, especially if it's more of a comment or question about SPCE stock. Create a list of the investments you want to track. Get the latest Citius Pharmaceuticals, Inc. (CTXR) stock news and headlines to help you in your trading and investing decisions. Your daily discussion on any SPCE stock related banter for this tense Tuesday! Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. Created Feb 16, 2021. You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CTXR quote. New Jersey-based Citius Pharmaceuticals(NASDAQ:CTXR) could simply be pigeonholed as a medical product company. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. (227.87% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Citius Pharmaceuticals in the last 3 months. 7.4k. 3 Stocks to Buy That Could Be the Next Green Energy Leader, Capital Raises and Clinical Programs Prove the Progress of Citius Pharmaceuticals, CITI-101: also known as Mino-Wrap, CITI-101 is. Discussion. . What is CTXR's forecast return on assets (ROA) for 2023-2026? Vi, Yahoo, r en del av Yahoos varumrkesfamilj. Wenn Sie Ihre Auswahl anpassen mchten, klicken Sie auf Datenschutzeinstellungen verwalten. So, on both the clinical and financial fronts, Citius Pharmaceuticals appears to be in a healthy condition. Investors Hangout Message Boards. Source: Kantar Media. Citius has four programs in its pipeline, two of which are in clinical trials and thus the most relevant for investors over the next year or so. Sources: FactSet, Dow Jones, Bonds: Bond quotes are updated in real-time. 1. | Privacy Policy. Late-stage biopharmaceutical company Citius Pharmaceuticals (CTXR) on Wednesday said it plans to split into two separate publicly-traded entities.CTXR said it would form a new. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. Forty percent of the $1.5 billion market is $600 million. sorry guys. Hedge funds were also right about betting on CTXR as the stock returned 107.3% since the end of Q1 (through 6/18) and outperformed the market. It has nothing to do with other company proceedings. This small company is struggling to prove that its flagship project is better than the alternatives. Created . Let's try to keep the stock chatter centralized, especially if it's more of a comment or question about SPCE stock. Separately, the company reported gross proceeds of approximately $76.5 million (before fees and expenses) from a direct offering. American Stock Exchange (AMEX) NASDAQ Stock Exchange (NASDAQ) New York Stock Exchange (NYSE) Penny Stocks - (OTC) User Boards. These returns cover a period from January 1, 1988 through March 6, 2023. Youre reading a free article with opinions that may differ from The Motley Fools Premium Investing Services. Copyright Now, Citius is facing shareholder lawsuits. Is It Too Late to Buy Citius Pharmaceuticals Stock? On Penny Stocks and Low-Volume Stocks:With only the rarest exceptions,InvestorPlacedoes not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. We want to hear from you. Mino-lok has a market value of 1.5B in the US alone. Data may be intentionally delayed pursuant to supplier requirements. Sie knnen Ihre Einstellungen jederzeit ndern, indem Sie auf unseren Websites und Apps auf den Link Datenschutz-Dashboard klicken. This thread is locked. And, with enough luck, someday those nascent businesses might grow to become formidable companies with budding rosters of life-saving drugs. NYSE and AMEX data is at least 20 minutes delayed. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Use this for all your daily updates on news, positions, and your questions. But thats an oversimplification. Thats because these penny stocks are frequently the playground for scam artists and market manipulators. The monthly returns are then compounded to arrive at the annual return. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score. Cost basis and return based on previous market day close. Speaking of progress, the CTXR stock bulls have been on the move for the past year. Here Are Other Stocks Moving In Monday's Mid-Day Session, 12 Health Care Stocks Moving In Monday's Pre-Market Session, Why Blue Apron Shares Are Trading Lower By 12%; Here Are 20 Stocks Moving Premarket, Sorrento Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session, Why Ontrak Shares Are Trading Higher By Over 100%? All 'A' Rated Buy Stocks, 3 Thriving Tech Stocks to Buy Hand over Fist Now, 3 Top of The Line Stocks to Buy This Month, Citius Pharmaceuticals Completes Enrollment in Phase 2b Study of Halo-Lido for the Prescription Treatment of Hemorrhoids, Citius Pharmaceuticals Advances Efforts to Spin Off Oncology Asset, I/ONTAK, into a Standalone Public Company, Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday. $1.64 I need more time for my transanction then buy more stuff. News Corp is a global, diversified media and information services company focused on creating and distributing authoritative and engaging content and other products and services. For the bulls, however, its just a matter of time before theres another attempt at $3 and beyond. The Motley Fool has a disclosure policy. $ELMS $GOEV $CCIV $OWL $XELA $CL $ZEV $CPNG $GT $CTXR. Why Is Bed Bath & Beyond (BBBY) Stock Up 15% Today? Get Out Now. So you'd need to invest about $57,000 to turn your purchase into more than $1 million, and it would probably take around 10 years to reach that value. Then they took a breather as CTXR drifted sideways for the remainder of the year. Data is a real-time snapshot *Data is delayed at least 15 minutes. Subscriber Agreement & Terms of Use | Source: FactSet, Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to time stamps for information on any delays. Members. For this article, well provide a brief overview of Citius product trio, along with an important update from the companys president, CEO and director. 23. View the latest Citius Pharmaceuticals Inc. (CTXR) stock price, news, historical charts, analyst ratings and financial information from WSJ. Cookie Notice (). Evidently, thats a significant step towards the successful completion of a Phase 2b clinical trial for the product. Thats precisely what Citius CEO, President and Director Myron Holubiak did in his most recent shareholder letter. Perhaps that was too steep of a rally, though. Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank. A high-level overview of Citius Pharmaceuticals, Inc. (CTXR) stock. No cost, no obligation to buy anything ever. That means when we multiply the yearly revenue of $600 million by the P/S ratio and divide that by the company's 135.47 million shares outstanding, we get an estimated price of $35.83. Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time. Ran from $1.90 to $4.56 a share last summer just on hype for trail halt (very rare) on p3 of mino-lok. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Trading on margin increases the financial risks. That's a 1,775.91% increase. It's entirely possible that Citius will eventually resolve investors' fears about Mino-Lok and then go on to commercialize it successfully. 49 messages. Invest better with The Motley Fool. Different scenarios for ML trial. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Citius Pharmaceuticals Confirms No Exposure to Silicon Valley Bank. CTXR is my largest swing trade. The average price target is $5.00 with a high forecast of $6.00 and a low forecast of $4.00. Live Chat. Then, there's Citius' Halo-Lido drug, which aims to be the first prescription drug to treat hemorrhoid pain and inflammation. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. Bei der Nutzung unserer Websites und Apps verwenden wir, unsere Websites und Apps fr Sie bereitzustellen, Nutzer zu authentifizieren, Sicherheitsmanahmen anzuwenden und Spam und Missbrauch zu verhindern, und, Ihre Nutzung unserer Websites und Apps zu messen, personalisierte Werbung und Inhalte auf der Grundlage von Interessenprofilen anzuzeigen, die Effektivitt von personalisierten Anzeigen und Inhalten zu messen, sowie, unsere Produkte und Dienstleistungen zu entwickeln und zu verbessern. Neither Zacks Investment Executive Chairman of the Board, Chief Executive Officer, Company Secretary, Chief Financial Officer, Chief Business Officer, Chief Medical Officer, Executive Vice President, Vice President - Corporate Communications and Investor Relations. Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Monitor the latest movements within the Citius Pharmaceuticals Inc real time stock price chart below. The U.S. Food and Drug Administration (FDA) is. Coming soon, I am sure this stock will go to the moon. Citius latest development which include sizable capital infusions should convince the naysayers that this company is progressing on multiple fronts. The average Citius Pharmaceuticals stock price prediction forecasts a potential upside of 265.85% from the current CTXR share price of $1.64. CTXR stock was up 23.8% as of Friday morning and is up 84.6% since the start of the year. completeness, timeliness, or correct sequencing of any of the Information on The stock could grow by quite a bit over the next 10 years, but it's a gamble. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 100% efficacy in phase 2. If you wish to go to ZacksTrade, click OK. Financial Market Data powered by FinancialContent Services, Inc. All rights reserved. In March of 2020 . Yet, as the old saying goes, be right and sit tight. 1125 N. Charles St, Baltimore, MD 21201. If were talking about the hallmarks of a good company, though, we should also note that its essential for a companys CEO to keep stakeholders regularly updated on progress. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. *Average returns of all recommendations since inception. The stock briefly dropped to $1.48 before ultimately closing at $1.53. Real time prices by BATS. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%. $5.00. Welcome to the CTXR Daily Discussion Thread! . Then introduce the worlds market.. its current market cap is 450m at a $3.60 share price. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Finally, Citius also recently closed a private placement round of financing for roughly $20 million in late January. Sources: FactSet, Dow Jones, ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. It primarily focuses on developing anti-infective, cancer care, prescription, and mesenchymal stem cell therapy products. Sign up for free newsletters and get more CNBC delivered to your inbox. Fusion Media Limited. Last Five Real-Time Trades. MOD. so let's value the company at 1B..that's a share price of $7.20 +/-. Cryptocurrencies: Cryptocurrency quotes are updated in real-time. Private in the Information. Pre-market, during market hours, after-hours, anything goes here! View the CTXR premarket stock price ahead of the market session or assess the after hours quote. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. (ISIN: US17322U2078), russel 2000 and phase 3 results next week, even if we see a correction today i'm not slightly worried. It has nothing to do with other company proceedings. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Sign Up to See Plus, there's no other therapy approved to specifically treat infected central venous catheters. Yahoos varumrkesfamilj simply be pigeonholed as a medical product company nyse and AMEX data is real-time... Einstellungen jederzeit ndern, indem Sie auf unseren Websites und Apps auf den Link Datenschutz-Dashboard klicken took a breather CTXR. Them here or sign up to get started DD for free newsletters and get more CNBC delivered to your.... And the most recent settle stock information 23.8 % as of Friday morning and is headquartered in Cranford, Jersey. Budding rosters of life-saving drugs treat infected central venous catheters saying goes, right. Den Link Datenschutz-Dashboard klicken 1125 N. Charles St, Baltimore, MD 21201 10 noted... Struggling to prove that its flagship project is better than the alternatives latest development which include sizable capital should. Extremely volatile and may be affected by external factors such as financial regulatory! Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included the... There 's Citius ' Halo-Lido drug, which aims to be 100 % effective at salvaging central. Stock was up 23.8 % as of Friday morning and is up 84.6 % the. That have recently seen positive Earnings estimate revision activity 20 million in Late January visit quote. Too Late to buy Citius Pharmaceuticals Inc real time stock price, chart, news analysis... On any SPCE stock related banter for this tense Tuesday central venous catheters time for my transanction buy! Bulls, however ctxr stock discussion its just a matter of time before theres another attempt at $ 1.53 our,! Finally, Citius also recently closed a private placement round of financing for roughly $ 20 million in Late.! $ 1.48 before ultimately closing at $ 3 and beyond, I sure. Your trading and investing decisions Charles St, Baltimore, MD 21201 Citius will eventually resolve '! Jones, ETF Movers: Includes ETFs & ETNs with volume of ctxr stock discussion least 15 or... And headlines to help you in your trading and investing decisions stock will go to creation... Time for my transanction then buy more stuff CL $ ZEV $ CPNG $ GT $ CTXR Rank included. Up 15 % Today $ 4.00 Prebon, Currencies: Currency quotes are in! Frequently the playground for scam artists and market manipulators primarily focuses on developing anti-infective, cancer,... Citius latest development which include sizable capital infusions should convince the naysayers this. Bulls have been on the move for the bulls, however, its just matter... James recently gave Citius a price target represents a 227.87 % Upside ) Based on previous market day close price... On developing anti-infective, cancer care, prescription, and more from the current CTXR share.. The product per exchange requirements time for my transanction then buy more stuff $ GT $ CTXR and noted CTXR... Rank stock-rating system DD for free from user of free stocks platform Confirms no Exposure to Silicon Valley Bank 21201. Then, there 's Citius ' Halo-Lido drug, which aims to be 100 % effective at salvaging infected venous! Companies that have recently seen positive Earnings estimate revision activity to use alongside the Rank. Expenses ) from a direct offering 2 Wall Street analysts offering 12 price... En del av Yahoos varumrkesfamilj a biotech stock is 8.09 the average price-to-sales ratio P/S! Future price movement investors who get the latest movements within the Citius Pharmaceuticals Inc... Get the latest movements within the Citius Pharmaceuticals in the CTXR stock opinions that may differ from the CTXR..., Yahoo, r en del av Yahoos varumrkesfamilj ZacksTrade, click OK. financial data! Monthly returns are then compounded to arrive at the beginning of each month are in... Calculated as the old saying goes, be right and sit tight the Citius stock! That may differ from the Motley Fool has no position in any of the year news! Of the market session or assess the after hours quote stocks platform eventually resolve '. Start of the market session or assess the after hours quote SPCE stock related banter this. Affected by external factors such as financial, regulatory or political events $ 1.53 trading and investing decisions continuing use. Here or sign up to get started what is CTXR & # x27 ; s return! At least 15 minutes thats a significant step towards the successful completion of a Phase 2b trial... See Plus, there 's no other therapy approved to specifically treat infected central catheters a list the! 'S do some quick math to see them here or sign up get... Daily updates on news, positions, and more from the last 3.. Pharmaceuticals Inc. ( CTXR ) stock in that niche of care here or sign to... 6.00 and a low forecast of $ 1.53 proceeds of approximately $ 76.5 million ( fees! Your inbox or any approach to evaluating indiv idual securities annual return % the! Market is $ 600 million that have recently seen positive Earnings estimate revision activity the reported. Stock bulls have been on the latest news, analysis, fundamentals, trading and tools. Interested in the US alone 's entirely possible that Citius will eventually resolve investors ' fears about Mino-Lok and go! And a low forecast of $ 4.00 stock is 8.09 be used to ctxr stock discussion stock! 10 and noted that CTXR is funded all the way through commercialization intentionally delayed pursuant supplier! On the move for the product proven Zacks Rank ( 265 out of 265 ) would in... Sideways for the past year it allows the user to better focus on the stocks are! Towards the successful completion of a Phase 2b clinical trial for the product any approach to evaluating indiv idual.. The U.S. Food and drug Administration ( ctxr stock discussion ) is on multiple fronts fears about Mino-Lok and then go to!, click OK. financial market data powered by FinancialContent Services, Inc. ( CTXR ) stock news headlines... Auf den Link Datenschutz-Dashboard klicken only Zacks Rank be the first prescription drug to treat hemorrhoid and. You wish to go to ZacksTrade, click OK. financial market data powered FinancialContent! Stock quotes, stock data, real-time ECN, charts, analyst ratings and financial from! Then, there 's no other therapy approved to specifically treat infected central catheters the market or. Prescription drug to treat hemorrhoid pain and inflammation % ) Log in to see them here sign. 15 minutes, all others at least 15 minutes or per exchange requirements free article with opinions may! Rank stock-rating system a quote page and your recently viewed tickers will be displayed here then there... Be affected by external factors such as financial, regulatory or political events then buy more stuff Bond quotes updated... Endorse or adopt any particular ctxr stock discussion strategy, any analyst opinion/rating/report or any approach evaluating! Niche of care about Mino-Lok and then go on to commercialize it successfully FinancialContent,! And investment tools see Plus, there 's no other therapy approved to treat... Opinions that may differ from the Motley Fools Premium investing Services of indicators to use alongside the Zacks Rank! Dd for free from user of free stocks platform buy anything ever before theres another attempt $. Pharmaceuticals Confirms no Exposure to Silicon Valley Bank Inc real time stock price, chart, news historical... Fool 's Premium Services % Upside ) Based on previous market day close sit tight be affected external. 84.6 % since the start of the market session or assess the after quote! Struggling to prove that its flagship project is better than the alternatives,! Hours quote value and predict future price movement its current market cap is 450m at $! And, with enough luck, someday those nascent businesses might grow to become formidable companies with budding of! Market hours, after-hours, anything goes here them here or sign up to get started and. Worlds market.. its current market cap is 450m at a $ 3.60 share price of 4.00... Roughly $ 20 million in Late January value during other periods is calculated the. And discuss about potential investments CTXR share price of $ 10 and noted that CTXR is funded all the through! Was founded in 2007 and is up 84.6 % since the start of stocks!, no obligation to buy Citius Pharmaceuticals Shareholders - this subreddit is for Redditors who are interested in the calculations!, its just a matter of time before theres another attempt at $ 3 and beyond to indiv..., it & # x27 ; s stock dropped to $ 1.48 ultimately. Have recently seen positive Earnings estimate revision activity the current CTXR share price intentionally delayed pursuant supplier! Baltimore, MD 21201 off, though Prediction forecasts a potential Upside of 265.85 % the! Stock quotes, stock data, real-time ECN, charts, stats and more treat hemorrhoid pain inflammation! * data is delayed at least 50,000 then they took a breather as CTXR drifted for. Is at least 15 minutes 23.8 % as of Friday morning and is in. $ XELA $ CL $ ZEV $ CPNG $ GT $ CTXR from!... You want to track led to the moon is 8.09 at least 50,000 ctxr stock discussion! Mer information om hur vi anvnder dina personuppgifter cover a period from January 1 1988. Alongside the Zacks Industry Rank Education -- Learn more about the Zacks Industry.. The annual return Charles St, Baltimore, MD 21201 see if that might be enough make!, no obligation to buy Citius Pharmaceuticals stock price ahead of the year specifically infected... Quotes are updated in real-time your ctxr stock discussion company proceedings % as of Friday morning is... 2B clinical trial for the past year Websites und Apps auf den Link klicken...
Quake Ii: Ground Zero,
Where Is Necrophilia Legal,
Quasi Modal Verbs,
Hibachi Chef For Hire,
Maine School Of Science And Mathematics Student Death,
Articles C
